Congruence Therapeutics is a biotechnology company at the interface of computational and experimental drug discovery, designing novel small molecules to treat diseases caused by protein misfolding.
Congruence Therapeutics is a biotechnology company at the interface of computational and experimental drug discovery, designing novel small molecules to treat diseases caused by protein misfolding.